Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecanBurak Zeybek, Alessandro D. Santin|Scientific Reports|2020Cited by 60
Robotic type II B posterior exenteration for recurrent vaginal cancerWafa Khadraoui, Gulden Menderes, Levent Mutlu et al.|Gynecologic Oncology|2019Cited by 5
1948 Robotic Type II B Posterior Exenteration for Recurrent Vaginal CancerWafa Khadraoui, Gulden Menderes, Burak Zeybek et al.|Journal of Minimally Invasive Gynecology|2019Cited by 0